A business unit of Dechra Pharmaceuticals PLC, Dechra Veterinary Products specializes in the development and marketing of licensed branded pharmaceuticals.

Employing around 212 people, we operate in eleven European countries: Belgium, Denmark, Finland, France, Ireland, Netherlands, Norway, Portugal, Spain, Sweden and the UK as well as in the US. Our European business is located in Shrewsbury, England and in Uldum, Denmark.

What we do best

Our key areas of expertise span dermatology, endocrinology, equine medicine and ophthalmology.

Our major brands include:

• Vetoryl^® Capsules, for the treatment of canine hyperadrenocorticism (Cushing's syndrome)
• Dermatology brands Muricin^®, Animax^® Ointment and Animax^® Cream
• Felimazole^® Tablets, for treating feline hyperthyroidism
• Irap™ and Osteokine^® therapies for equine
• The ophthalmics Vetropolycin Ophthalmic Ointment^®, Vetropolycin HC Ophthalmic Ointment^®, Vetrachloracin Ophthalmic Ointment^®, Vetrogen Ophthalmic Ointment^® and Puralube^®

Dechra, putting you first.

We’re committed to developing new products and services that support the work of veterinary professionals and enhance the lives of their patients. Dechra will continue to invest in products and added-value services that deliver our promise to veterinary professionals and pet owners.